A comparison of the clinical outcomes of haploidentical transplantation and other graft sources in acute lymphoblastic leukemia: a systematic review and meta-analysis
: Most likely due to the availability of potential stem cell sources, there appears to be a growing usage of haploidentical (haplo) donors for cases of acute lymphoblastic leukemia involving high-risk features or relapse.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Weerapat Owattanapanich, Nattawut Leelakanok, Kleebsabai Sanpakit, Jassada Buaboonnam Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Hematology | Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Transplants